Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics
Recruiting now
Conditions studied: Substance Use Disorders (SUDs)
In brief
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
Key facts
- Study ID
- NCT07104396
- Run by
- Square2 Systems, Inc.
- People needed
- 20
- Starts
- 2025-07-02
- Expected to finish
- 2025-08-31
- Last updated by the study team
- 2025-08-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- At least 18 years
- PhD and/or MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher.
- Training or trained in substance use disorder (SUDs) research.
- Must state a specific interest in digital therapeutics for SUDs.
You may not qualify if…
- Those who do not meet inclusion criteria.
Where it is running
- Square 2 Systems — Hanover, New Hampshire, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.